What Is Acute Fatty Liver of Pregnancy?

Pregnancy can produce plenty of strange symptoms, from heartburn that feels like a small volcano to cravings that make pickles and peanut butter seem like culinary soulmates. Most changes are uncomfortable rather than dangerous. Acute fatty liver of pregnancy, however, belongs in a very different category.

Acute fatty liver of pregnancy, commonly abbreviated as AFLP, is a rare but potentially life-threatening pregnancy complication in which tiny droplets of fat accumulate inside liver cells and interfere with normal liver function. It usually appears during the third trimester, although it can occasionally develop shortly after delivery.

AFLP is an obstetric emergency. Without rapid diagnosis and treatment, it can lead to liver failure, dangerously low blood sugar, severe bleeding, kidney injury, infection, brain dysfunction, and complications for the baby. The reassuring news is that outcomes have improved dramatically as healthcare teams have become better at recognizing the condition and delivering the baby promptly.

What Happens to the Liver in AFLP?

The liver is the body’s biochemical multitasker. It processes nutrients, stores energy, removes waste, regulates blood sugar, produces proteins needed for clotting, and performs hundreds of other jobs without requesting a vacation day.

In acute fatty liver of pregnancy, the liver’s ability to process certain fatty acids becomes disrupted. Small fat droplets accumulate inside liver cells, a pattern called microvesicular steatosis. These droplets interfere with the cells’ energy-producing structures, known as mitochondria.

As more liver cells lose function, the liver may struggle to maintain blood glucose, produce clotting proteins, remove bilirubin, and clear toxic substances from the bloodstream. This explains why AFLP can affect far more than the liver. The kidneys, brain, pancreas, lungs, blood-clotting system, placenta, and fetus may all become involved.

AFLP Is Not the Usual Type of Fatty Liver Disease

Despite the name, AFLP is not simply ordinary fatty liver disease appearing during pregnancy. It is different from metabolic dysfunction-associated steatotic liver disease, formerly called nonalcoholic fatty liver disease.

AFLP is not caused by eating greasy meals, gaining an expected amount of pregnancy weight, or having an occasional cheeseburger. It is an abrupt, pregnancy-specific disorder associated with impaired fatty-acid metabolism. Dieting, exercising, or cutting fat from meals cannot treat it. Delivery and hospital-based medical support are required.

How Common Is Acute Fatty Liver of Pregnancy?

Estimates vary, but AFLP is generally thought to affect approximately 1 in 7,000 to 20,000 pregnancies. Its rarity creates a diagnostic challenge: early symptoms can look like ordinary third-trimester complaints, food poisoning, a stomach virus, or another pregnancy complication.

Most cases begin between about 30 and 38 weeks of pregnancy, with many diagnosed around 35 or 36 weeks. A smaller number become apparent during the immediate postpartum period. Therefore, delivery does not instantly remove the need for vigilance; symptoms and laboratory abnormalities may continue or briefly worsen before recovery begins.

What Causes Acute Fatty Liver of Pregnancy?

The complete cause is not fully understood. Current evidence points toward abnormalities in mitochondrial fatty-acid oxidation, the process cells use to convert certain fats into energy.

During late pregnancy, the metabolic demands of the mother, placenta, and fetus increase. If the fetus has a genetic fatty-acid oxidation disorder, partially processed fatty-acid products may accumulate and cross the placenta. A mother who carries a related genetic variant may have difficulty handling this increased metabolic load, contributing to liver-cell injury.

The Connection With LCHAD Deficiency

One of the best-known genetic associations involves long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, usually shortened to LCHAD deficiency. This rare inherited condition prevents the body from properly breaking down certain long-chain fatty acids.

Variants involving genes such as HADHA, HADHB, and, less commonly, CPT1A have been associated with fatty-acid oxidation problems and maternal liver disease during pregnancy. However, not every AFLP case involves an identifiable fetal or maternal mutation. A negative genetic test does not prove that the condition was misdiagnosed or eliminate the possibility of recurrence.

Who Is More Likely to Develop AFLP?

AFLP can occur without an obvious warning or traditional risk factor. Reported associations include:

• A previous pregnancy affected by AFLP
• A fetus with a fatty-acid oxidation disorder
• A first pregnancy
• Twins, triplets, or another multiple pregnancy
• Carrying a male fetus
• Preeclampsia or HELLP syndrome
• Certain metabolic conditions

These factors are associations, not predictions. Most people with one or more of them will never develop AFLP, while some diagnosed patients have none of them. There is no routine screening test that can reliably forecast every case.

Symptoms of Acute Fatty Liver of Pregnancy

The first symptoms are often frustratingly vague. A person may initially feel as though they have the flu, a stomach bug, or an unusually rough week of late pregnancy.

Early Symptoms

• Persistent nausea or vomiting
• Loss of appetite
• Unusual fatigue or weakness
• A general feeling of being seriously unwell
• Pain in the upper abdomen, particularly the right side
• Headache
• Excessive thirst or frequent urination

Signs of Progressing Liver Dysfunction

• Yellow skin or yellowing in the whites of the eyes
• Dark urine or unusually pale stool
• Easy bruising, bleeding, or oozing from injection sites
• Confusion, unusual sleepiness, agitation, or poor concentration
• Reduced urine output
• Abdominal swelling
• Shortness of breath
• Dizziness, sweating, trembling, or faintness from low blood sugar

Late-pregnancy nausea should not automatically be dismissed as “morning sickness making an encore.” New vomiting in the third trimester, particularly when combined with abdominal pain, weakness, jaundice, confusion, or reduced fetal movement, deserves urgent evaluation.

How Is AFLP Diagnosed?

No single symptom or routine blood test proves that a patient has AFLP. Diagnosis depends on the overall pattern, the stage of pregnancy, laboratory abnormalities, physical findings, and the exclusion of other conditions.

The initial evaluation commonly includes:

• A complete blood count
• AST and ALT liver-enzyme tests
• Bilirubin levels
• Blood glucose
• Kidney-function tests, including creatinine
• Prothrombin time and INR to assess clotting
• Electrolytes, ammonia, uric acid, and other metabolic tests
• Urine testing for protein and signs of kidney dysfunction
• Tests for viral hepatitis, medication toxicity, and other liver disorders
• Fetal monitoring and obstetric ultrasound

Common Laboratory Findings

AFLP may cause elevated liver enzymes and bilirubin, an increased white blood cell count, low blood sugar, prolonged clotting times, elevated uric acid, increased ammonia, and worsening kidney function. Platelets may be low, especially when AFLP overlaps with preeclampsia or HELLP syndrome.

One particularly important clue is impaired liver function rather than liver-enzyme elevation alone. Someone with only moderately elevated AST and ALT may still be critically ill if their glucose is falling, INR is rising, creatinine is worsening, or mental status is changing.

The Swansea Criteria

Clinicians may use the Swansea criteria to organize evidence supporting an AFLP diagnosis. The criteria include vomiting, abdominal pain, excessive thirst or urination, encephalopathy, elevated bilirubin, low glucose, elevated white blood cells, increased liver enzymes, high ammonia or uric acid, kidney impairment, coagulopathy, certain ultrasound findings, and microvesicular fat on liver biopsy.

Traditionally, six or more features in the absence of another explanation support the diagnosis. The Swansea criteria are helpful, but they do not replace clinical judgment. Pregnancy itself can affect several laboratory values, and patients do not always arrive with a textbook-perfect collection of abnormalities.

Are Ultrasound or Liver Biopsy Necessary?

An ultrasound may show a bright-looking liver, fluid in the abdomen, gallstones, or another explanation for the symptoms. However, ultrasound can appear normal in AFLP because microscopic fat droplets are difficult to detect.

A liver biopsy can show the characteristic microvesicular steatosis, but it is rarely required. Many patients have significant clotting abnormalities, making an invasive biopsy unnecessarily risky when the clinical and laboratory evidence already supports urgent treatment.

AFLP Versus HELLP Syndrome

AFLP and HELLP syndrome can overlap, and both may occur with preeclampsia. HELLP stands for hemolysis, elevated liver enzymes, and low platelet count. Distinguishing the conditions may require repeated laboratory tests and evaluation by obstetric, liver, anesthesia, and critical-care specialists.

Other possible diagnoses include viral hepatitis, medication-related liver injury, gallbladder disease, bile-duct obstruction, intrahepatic cholestasis of pregnancy, autoimmune hepatitis, severe hyperemesis, sepsis, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome.

How Is Acute Fatty Liver of Pregnancy Treated?

The definitive treatment is delivery of the baby and placenta after the mother has been stabilized as much as possible. Waiting for the liver to recover while the pregnancy continues is generally unsafe because the metabolic trigger remains present.

Stabilization may include:

• Intravenous glucose to prevent or correct hypoglycemia
• Careful fluid and electrolyte management
• Blood products when clinically necessary to treat severe coagulopathy or bleeding
• Management of high blood pressure or preeclampsia
• Kidney support, including dialysis in severe cases
• Treatment of infection, pancreatitis, respiratory failure, or encephalopathy
• Continuous maternal and fetal monitoring
• Early involvement of anesthesia, critical care, neonatology, hepatology, and blood-bank teams

Does AFLP Always Require a Cesarean Delivery?

No. The safest delivery method depends on cervical readiness, fetal status, bleeding risk, gestational age, and the mother’s condition. A stable patient with a favorable cervix may be able to deliver vaginally. Cesarean delivery may be necessary when rapid birth is required or when the mother or fetus is unstable.

Cesarean surgery is not automatically simpler in AFLP because impaired clotting increases the risk of surgical bleeding. The delivery plan must be individualized rather than chosen by a one-size-fits-all rule.

What Happens After Delivery?

Removing the fetus and placenta stops the pregnancy-related trigger, but recovery is not instantaneous. Liver, kidney, glucose, and clotting abnormalities may remain severe for several days. Some patients initially worsen after delivery before improvement becomes obvious.

Close postpartum monitoring may include frequent blood tests, glucose checks, neurological assessments, fluid-balance measurements, bleeding surveillance, and respiratory support. Many patients require care in an intensive care unit.

When the condition is recognized and managed promptly, liver function often begins improving during the first several days and may return toward normal within approximately one to two weeks. Recovery can take longer when kidney failure, infection, major hemorrhage, pancreatitis, or other complications occur. Liver transplantation is rarely necessary but may be considered for persistent, irreversible liver failure.

What Does AFLP Mean for the Baby?

The baby may need early delivery and neonatal intensive care, especially when the pregnancy is preterm or fetal monitoring is abnormal. The newborn may be evaluated for low blood sugar, heart problems, muscle weakness, liver dysfunction, and inherited fatty-acid oxidation disorders.

Because certain fetal metabolic conditions may be associated with maternal AFLP, clinicians may recommend metabolic testing and genetic counseling for the baby and parents. Early identification matters because some fatty-acid oxidation disorders require specific feeding schedules, avoidance of fasting, and emergency treatment during illness.

Can Acute Fatty Liver of Pregnancy Be Prevented?

There is currently no proven diet, medication, supplement, or lifestyle program that prevents AFLP. Standard prenatal care remains important, but normal earlier appointments and laboratory results do not guarantee that the condition cannot appear later.

The most practical protective step is recognizing warning signs and reporting them promptly. A pregnant person should never feel embarrassed about seeking evaluation for symptoms that turn out to be harmless. Obstetric triage teams would much rather evaluate a false alarm than meet a genuine emergency several hours too late.

Can AFLP Return in a Future Pregnancy?

Recurrence is possible, although the precise risk varies and is difficult to predict. Before another pregnancy, a person with a history of AFLP should consider consultation with a maternal-fetal medicine specialist and, when appropriate, a hepatologist or genetic counselor.

A future pregnancy may involve baseline liver and kidney tests, a review of previous medical records, assessment for fatty-acid oxidation disorders, and closer monitoring during the third trimester. Patients should receive a clear plan explaining which symptoms require same-day testing or emergency evaluation.

Experiences Related to AFLP: A Composite Care Journey

The following example is a composite scenario based on patterns commonly encountered in AFLP care. It does not describe one identifiable patient and should not be used to diagnose an individual case.

Imagine someone who is 36 weeks pregnant and has enjoyed an uncomplicated pregnancy. Over two days, she develops nausea and loses interest in food. At first, she blames a restaurant meal. Late pregnancy already makes sleeping, bending, and locating one’s own feet feel like advanced athletic events, so fatigue does not seem particularly suspicious.

By the following morning, the nausea has progressed to repeated vomiting. She develops a steady ache beneath her right ribs and feels unusually thirsty. Her family notices that she looks pale and has trouble following a conversation. She calls her obstetric unit and is told to come in immediately.

At the hospital, fetal monitoring begins while blood and urine samples are collected. The initial laboratory results show elevated bilirubin and liver enzymes, low glucose, impaired kidney function, and a prolonged clotting time. The team repeats several tests, excludes common infections and medication-related causes, and recognizes a pattern concerning for AFLP.

The pace of care changes quickly. What began as a suspected stomach bug becomes a coordinated obstetric emergency. An obstetrician discusses delivery. An anesthesiologist reviews the bleeding risk. A critical-care physician helps stabilize glucose and circulation. The blood bank prepares appropriate products, and a neonatal team gets ready to care for a potentially preterm baby.

For patients and families, this sudden acceleration can be emotionally disorienting. A carefully planned birth may become an urgent induction or Cesarean delivery. There may be little time to process the change, contact relatives, or worry about whether the hospital bag contains the correct socks. Medical teams must explain decisions clearly while continuing time-sensitive treatment.

After delivery, the baby may go to a neonatal unit while the mother remains in intensive care. This separation can be one of the hardest parts of the experience. The mother may feel exhausted, confused, frightened, or guilty despite having done nothing to cause the condition. Partners may move between hospital units while trying to understand unfamiliar terms such as INR, bilirubin, creatinine, hypoglycemia, and encephalopathy.

Recovery often appears in small laboratory victories. Blood sugar stabilizes. Clotting tests stop worsening. Urine output increases. Bilirubin begins to fall. Mental clarity returns. The improvement may be gradual rather than cinematic, but each trend in the right direction matters.

Going home can bring relief alongside anxiety. Survivors may worry whenever they feel tired, nauseated, or uncomfortable beneath the ribs. Follow-up appointments usually include repeat liver, kidney, blood-count, and clotting tests. Emotional recovery may require more time than physical recovery, particularly after an emergency delivery, intensive-care admission, major hemorrhage, or separation from the newborn.

Before a later pregnancy, reviewing the original records can be valuable. A maternal-fetal medicine specialist can clarify how the diagnosis was reached, whether genetic or metabolic testing was completed, and how monitoring should be structured next time. A written plan often helps patients feel less as though they are waiting for an invisible trapdoor to open.

The central lesson from these experiences is not that every episode of nausea signals liver failure. It is that a new combination of persistent vomiting, abdominal pain, jaundice, confusion, excessive thirst, profound weakness, or reduced fetal movement in late pregnancy deserves prompt medical attention. In AFLP, listening to the body’s unusually loud alarm bells can make a decisive difference.

Conclusion

Acute fatty liver of pregnancy is rare, but its ability to progress rapidly makes awareness essential. The condition usually develops late in pregnancy when impaired fatty-acid metabolism causes microscopic fat accumulation and acute liver dysfunction.

Persistent nausea, vomiting, upper abdominal pain, jaundice, low blood sugar, clotting abnormalities, kidney dysfunction, or confusion can provide important clues. Diagnosis relies on the complete clinical and laboratory pattern rather than one perfect test. Prompt delivery, intensive supportive care, postpartum monitoring, and newborn metabolic evaluation offer the best chance of recovery.

Most importantly, AFLP is not the patient’s fault. It is not caused by an imperfect diet, normal pregnancy weight gain, or failure to follow prenatal advice. Fast recognition and coordinated medical care are far more important than searching for something the patient supposedly did wrong.